Institutional shares held 115 Million
337K calls
337K puts
Total value of holdings $357M
$1.04M calls
$1.05M puts
Market Cap $590M
190,232,000 Shares Out.
Institutional ownership 60.52%
# of Institutions 170


Latest Institutional Activity in SANA

Top Purchases

Q1 2025
Citadel Advisors LLC Shares Held: 3.4M ($10.5M)
Q1 2025
Clearline Capital LP Shares Held: 411K ($1.27M)
Q1 2025
Balyasny Asset Management LLC Shares Held: 354K ($1.1M)
Q1 2025
Nuveen, LLC Shares Held: 351K ($1.09M)
Q1 2025
Ubs Group Ag Shares Held: 729K ($2.26M)

Top Sells

Q2 2025
Triumph Capital Management Shares Held: 14.7K ($45.5K)
Q1 2025
Vanguard Group Inc Shares Held: 7.87M ($24.4M)
Q1 2025
State Street Corp Shares Held: 5.49M ($17M)
Q1 2025
Morgan Stanley Shares Held: 826K ($2.56M)
Q1 2025
Ci Private Wealth, LLC Shares Held: 311K ($966K)

About SANA

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia; SG221 and SG239 for the treatment of multiple myeloma; and SG328 for ornithine transcarbamylase deficiency. It also develops SG418 for sickle cell disease and beta-thalassemia; SC291, a CD19 allogeneic T cell therapy; SC255 for multiple myeloma; SC451 for type I diabetes mellitus; and SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington's disease. Sana Biotechnology, Inc. was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. The company was incorporated in 2018 and is headquartered in Seattle, Washington.


Insider Transactions at SANA

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
115K Shares
From 4 Insiders
Grant, award, or other acquisition 44.4K shares
Exercise of conversion of derivative security 70.8K shares
Sell / Disposition
609K Shares
From 5 Insiders
Open market or private sale 591K shares
Payment of exercise price or tax liability 18.5K shares

Track Institutional and Insider Activities on SANA

Follow Sana Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SANA shares.

Notify only if

Insider Trading

Get notified when an Sana Biotechnology, Inc. insider buys or sells SANA shares.

Notify only if

News

Receive news related to Sana Biotechnology, Inc.

Track Activities on SANA